|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn957997445 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160503s2016 nyu ob 001 0 eng |
| 010 |
|
|
|a 2019716120
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d EBLCP
|d N$T
|d YDX
|d AGLDB
|d SNK
|d DKU
|d AUW
|d INTCL
|d MHW
|d BTN
|d IGB
|d D6H
|d VTS
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d VLY
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 961204944
|
| 020 |
|
|
|a 9781634853774
|q (pdf)
|
| 020 |
|
|
|a 1634853776
|
| 020 |
|
|
|z 9781634853668
|q (hardcover)
|
| 020 |
|
|
|z 1634853660
|q (hardcover)
|
| 029 |
1 |
|
|a AU@
|b 000062422306
|
| 035 |
|
|
|a (OCoLC)957997445
|z (OCoLC)961204944
|
| 050 |
0 |
0 |
|a RC801
|
| 060 |
|
4 |
|a WI 140
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.3/3
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Disorders of gastrointestinal systems and clinical manifestations /
|c Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|
| 490 |
1 |
|
|a Digestive diseases--research and clinical developments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis
|
| 505 |
8 |
|
|a 2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES
|
| 505 |
8 |
|
|a RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD)
|
| 505 |
8 |
|
|a 1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP
|
| 505 |
8 |
|
|a 5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Gastrointestinal system
|x Diseases
|x Pathophysiology.
|
| 650 |
|
2 |
|a Gastrointestinal Diseases
|x physiopathology
|
| 650 |
|
6 |
|a Tractus gastro-intestinal
|x Maladies.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 700 |
1 |
|
|a Rajagopal, Senthilkumar,
|e editor.
|
| 700 |
1 |
|
|a Murugan, Sengottuvelan,
|e editor.
|
| 700 |
1 |
|
|a Ramachandran, Saravanan,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Disorders of gastrointestinal systems and clinical manifestations.
|d New York : Nova Biomedical, [2016]
|z 9781634853668
|w (DLC) 2016940560
|
| 830 |
|
0 |
|a Digestive diseases--research and clinical developments series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345681
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4691155
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1345681
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13052454
|
| 994 |
|
|
|a 92
|b IZTAP
|
